Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion type Assertion NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_head.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion description "[Seven patients with HCC who underwent transcatheter arterial embolization (TAE) exhibited a gradual increase in serum HGF levels up to day 4 after treatment; these higher levels were maintained until day 7, although AST reached a peak on day 2 and then decreased gradually.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion evidence source_evidence_literature NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion SIO_000772 7806142 NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion wasDerivedFrom befree-20140225 NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.
- NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_assertion wasGeneratedBy ECO_0000203 NP658066.RALJFxdBs50fyJ74PIoKIlwXBLc3F60gLwYk-nD_pZu50130_provenance.